ACS Nano · 2023 · 77 citations · 58 references
PharmacyOncologyPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineLipid-based NanoparticlesMagnetic Field-responsive Drug DeliveryMagnetic NanomaterialsMagnetic-responsive Drug DeliveryNanomedicineLipid NanoparticlesLipid-based Delivery SystemsMagnetic Drug Delivery SystemsMagnetic Nanoparticle Drug CarriersMagnetic Nanoparticle Drug DeliveryMagnetic NanoparticlesStimuli-responsive DeliveryStimuli-responsive Delivery Systems
High Resolution Image Download MS PowerPoint Slide Glioblastoma multiforme (GBM) is a devastating tumor of the central nervous system, currently missing an effective treatment. The therapeutic gold standard consists of surgical resection followed by chemotherapy (usually with temozolomide, TMZ) and/or radiotherapy. TMZ does not, however, provide significant survival benefit after completion of treatment because of development of chemoresistance and of heavy side effects of systemic administration. Improvement of conventional treatments and complementary therapies are urgently needed to increase patient survival and quality of life. Stimuli-responsive lipid-based drug delivery systems offer promising prospects to overcome the limitations of the current treatments. In this work, multifunctional lipid-based magnetic nanovectors functionalized with the peptide angiopep-2 and loaded with TMZ (Ang-TMZ-LMNVs) were tested to enhance specific GBM therapy on an in vivo model. Exposure to alternating magnetic fields (AMFs) enabled magnetic hyperthermia to be performed, that works in synergy with the chemotherapeutic agent. Studies on orthotopic human U-87 MG-Luc2 tumors in nude mice have shown that Ang-TMZ-LMNVs can accumulate and remain in the tumor after local administration without crossing over into healthy tissue, effectively suppressing tumor invasion and proliferation and significantly prolonging the median survival time when combined with the AMF stimulation. This powerful synergistic approach has proven to be a robust and versatile nanoplatform for an effective GBM treatment.
58
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
K. Maier-Hauff, Frank Ulrich, Dirk Nestler et al. · Journal of Neuro-Oncology · 2010 · 1.4K citations · Full text
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Milton B. Yatvin, John N. Weinstein, Warren H. Dennis et al. · Science · 1978 · 937 citations